Oxycodone Hydrochloride
- Product NDC
- 31722-111
- 11-digit product format
- 317220111
- Labeler code
- 31722
- Product ID
- 31722-111_76f2b4ea-6ad1-4bd5-8a1c-c4c04fd91b74
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxycodone Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- NDA022272
- Marketing category
- NDA
- Marketing start
- 2020-12-23
- Marketing end
- 0000-00-00
- Substance
- OXYCODONE HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 31722-111 | D | Discontinued by firm | 2026-08-11 | ||
| excluded package | package | 31722-111 | 31722-111-01 | D | Discontinued by firm | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 31722-111-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 31722-111-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 31722-111-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 31722-111-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 31722-111-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 31722-111-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 31722-111-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 31722-111-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 31722-111-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 31722-111-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 31722-111-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 31722-111-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 31722-111-01 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 31722-111-01 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 31722-111-01 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022272-001 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | |
| N022272-002 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | |
| N022272-003 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | |
| N022272-004 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | |
| N022272-005 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | |
| N022272-006 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | |
| N022272-007 | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022272-001 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-001 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-001 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-001 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-001 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-001 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | |
| N022272-001 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | |
| N022272-001 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-001 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-001 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-001 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-001 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | |
| N022272-001 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | |
| N022272-001 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | |
| N022272-001 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | |
| N022272-002 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-002 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-002 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-002 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-002 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-002 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | |
| N022272-002 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | |
| N022272-002 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-002 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-002 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-002 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-002 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | |
| N022272-002 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | |
| N022272-002 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | |
| N022272-002 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | |
| N022272-003 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-003 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-003 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-003 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-003 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-003 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | |
| N022272-003 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | |
| N022272-003 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-003 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-003 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-003 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-003 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | |
| N022272-003 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | |
| N022272-003 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | |
| N022272-003 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | |
| N022272-004 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-004 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-004 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-004 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-004 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-004 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | |
| N022272-004 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | |
| N022272-004 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-004 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-004 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-004 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-004 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | |
| N022272-004 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | |
| N022272-004 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | |
| N022272-004 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | |
| N022272-005 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-005 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-005 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-005 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-005 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-005 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | |
| N022272-005 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | |
| N022272-005 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-005 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-005 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | |
| N022272-005 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | |
| N022272-005 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | |
| N022272-005 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | |
| N022272-005 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | |
| N022272-006 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | |
| N022272-006 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | |
| N022272-006 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | |
| N022272-006 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | |
| N022272-006 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | |
| N022272-006 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-006 | OXYCONTIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-007 | OXYCONTIN | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-006 | OXYCONTIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022272-007 | OXYCONTIN | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-006 | OXYCONTIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022272-007 | OXYCONTIN | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-006 | OXYCONTIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022272-007 | OXYCONTIN | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-006 | OXYCONTIN | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022272-007 | OXYCONTIN | 80MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022272-001 | OXYCONTIN | 10MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022272-002 | OXYCONTIN | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022272-003 | OXYCONTIN | 20MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022272-004 | OXYCONTIN | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-04-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022272-005 | OXYCONTIN | 40MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2010-04-05 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-001 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9492393 | 2027-08-24 | U-1556 | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9763933 | 2027-08-24 | Drug product | 2017-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9770416 | 2027-08-24 | Drug product | 2017-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 9775808 | 2027-08-24 | Drug product | 2017-10-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-002 | 8894987 | 2030-03-29 | Drug product | 2014-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 11304908 | 2027-08-24 | Drug product | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 11304909 | 2027-08-24 | U-1556 | 2022-04-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 11964056 | 2027-08-24 | Drug product | 2024-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 12246094 | 2027-08-24 | Drug product | 2025-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 12280152 | 2027-08-24 | Drug product | 2025-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 8808741 | 2027-08-24 | U-1556 | 2014-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 8894988 | 2027-08-24 | Drug product | 2014-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 9492389 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 9492391 | 2027-08-24 | U-1556 | 2016-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022272-003 | 9492392 | 2027-08-24 | Drug product | 2016-11-16 | 011fe1cb6892… |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 31722-111-01 | 2023-01-30 | C162847 | 48780-1 | f386c64a-35c0-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 1950 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-111-01 | EA - Each | 31722-111 | 60fe3fdd-32ea-4fa1-a879-209c7cf5fa4c | 1 | 2021-06-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OxyContin | OXYCODONE HYDROCHLORIDE | Knoa Pharma LLC | bfdfe235-d717-4855-a3c8-a13d26dadede | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 022272 NDA022272 |
| OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | c2c57ae7-86b9-47bb-a31b-ed1c4327ce7f | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 022272 NDA022272 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 31722-111-01 | 31722011101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-111-01) | 2020-12-23 | 0000-00-00 | No | No | Current |